Literature DB >> 16644828

Diagnosis and treatment of chronic hepatitis C infection.

Keyur Patel1, Andrew J Muir, John G McHutchison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16644828      PMCID： PMC1450048          DOI： 10.1136/bmj.332.7548.1013

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.

Authors:  John G McHutchison; Ralf Bartenschlager; Keyur Patel; Jean-Michel Pawlotsky
Journal:  J Hepatol       Date:  2005-12-07       Impact factor: 25.083

Review 2.  Noninvasive measures of liver fibrosis.

Authors:  Don C Rockey; D Montgomery Bissell
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 3.  American Gastroenterological Association technical review on the management of hepatitis C.

Authors:  Jules L Dienstag; John G McHutchison
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

Review 4.  The role of liver biopsy in chronic hepatitis C.

Authors:  Jules L Dienstag
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 5.  Interventions to enhance patient adherence to medication prescriptions: scientific review.

Authors:  Heather P McDonald; Amit X Garg; R Brian Haynes
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

Review 6.  Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response.

Authors:  Amrita Sethi; Mitchell L Shiffman
Journal:  Clin Liver Dis       Date:  2005-08       Impact factor: 6.126

7.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

8.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors:  Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

9.  Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

Authors:  John G McHutchison; Michael Manns; Keyur Patel; Thierry Poynard; Karen L Lindsay; Christian Trepo; Jules Dienstag; William M Lee; Carmen Mak; Jean-Jacques Garaud; Janice K Albrecht
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

Review 10.  Evaluation of liver fibrosis: a concise review.

Authors:  Nezam H Afdhal; David Nunes
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864
View more
  14 in total

1.  Chronic hepatitis C.

Authors:  Kosh Agarwal; Timothy J S Cross; Charles Gore
Journal:  BMJ       Date:  2007-01-13

2.  Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.

Authors:  Massimo Sartori; Silvano Andorno; Michela Pagliarulo; Cristina Rigamonti; Cristina Bozzola; Patrizia Pergolini; Roberta Rolla; Anna Suno; Renzo Boldorini; Giorgio Bellomo; Emanuele Albano
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

3.  Hepatitis C infection and chronic renal diseases.

Authors:  Aline Gonzalez Vigani
Journal:  Hepatol Int       Date:  2012-03-15       Impact factor: 6.047

4.  Comparison of the abbott 7000 and bayer 340 systems for measurement of hepatitis C virus load.

Authors:  Helene C Highbarger; Zonghui Hu; Shyam Kottilil; Julia A Metcalf; Michael A Polis; M B Vasudevachari; H Clifford Lane; Robin L Dewar
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

5.  Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C.

Authors:  Donald E Bailey; Lawrence Landerman; Julie Barroso; Patricia Bixby; Merle H Mishel; Andrew J Muir; Lisa Strickland; Elizabeth Clipp
Journal:  Psychosomatics       Date:  2009 Mar-Apr       Impact factor: 2.386

6.  Operating on a patient with hepatitis C.

Authors:  Sonal Asthana; Norman Kneteman
Journal:  Can J Surg       Date:  2009-08       Impact factor: 2.089

7.  Risk factors for the development of depression in patients with hepatitis C taking interferon-α.

Authors:  Kimberley J Smith; Suzanne Norris; Cliona O'Farrelly; Shane M O'Mara
Journal:  Neuropsychiatr Dis Treat       Date:  2011-05-15       Impact factor: 2.570

8.  Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study.

Authors:  Huy A Tran; Tracey L Jones; Robert Gibson; Glenn Em Reeves
Journal:  BMC Endocr Disord       Date:  2011-05-24       Impact factor: 2.763

9.  Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial.

Authors:  Mostafa Yakoot; Amel Salem
Journal:  BMC Gastroenterol       Date:  2012-04-12       Impact factor: 3.067

10.  Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a.

Authors:  Isabelle Moreau; John Levis; Orla Crosbie; Elizabeth Kenny-Walsh; Liam J Fanning
Journal:  Virol J       Date:  2008-07-09       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.